Development

Jane Wan is a freelance writer based in Singapore.

Articles

The Japanese government is eager to jumpstart its generic-drug market, but changes must come first.

Report From: Japan

The authors investigate whether the addition of an antioxidant could be used to stabilize the solvent ethyl lactate by preventing the formation of peroxides

Ethyl Lactate as a Pharmaceutical-Grade Excipient and Development of a Sensitive Peroxide Assay

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Taking a cue from its electronics industry, Taiwan is seeking to put its biotechnology and pharmaceutical industries on the map. An interactive map shows pharmaceutical activity in Taiwan.

Taiwan, No Longer a Life-Sciences Island Unto Itself

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Manufacturers of therapeutic monoclonal antibodies consider new paradigms in purification technologies.

Easing the Bottleneck

Jim Greenwood is president and CEO of the Biotechnology Innovation Organization (BIO). He represented Pennsylvania’s 8thÂ district in the US House of Representatives from 1993 to 2005.

The organizations' presidents discuss market exclusivity, approval processes, and pending legislation.

Industry Leaders Debate Follow-on Biologics Pathway

Technology can solve enterprise-level problems.

Shop Floor and Top Floor, Unite!

Pradeep Karatgil is from Custom Pharmaceutical Services, Dr Reddy's Laboratories Ltd (India).

Raviraj Pillai is Vice President, Integrated Product Development, at Dr Reddy's Laboratories Ltd (India). ravip@drreddys.com

Orally disintegrating tablets offer numerous advantages compared with traditional tablets and capsules, and can be an effective solution for developing line extensions of currently marketed therapies.

Orally disintegrating tablets: the path to improved patient compliance and enhanced life cycle management

Also, Roche's Avastin trial does not meet endpoint; Innate Pharma names regulatory VP; more...

Company and People Notes: CIGNA and Merck Agree on Drug Pricing Plan; Kathleen Sebelius Confirmed as head of HHS; More

Also: Sanofi-aventis acquires BiPar Sciences; FDA issues Warning Letter to Chinese heparin manufacturer; Halo Pharmaceutical appoints chief scientific officer; more...

Company and People Notes: GSK Acquires Stiefel Laboratories; Roche Announces Changes at Genentech; More...

The United States Pharmacopeial (USP) Convention signed a memorandum of understanding (MOU) with the Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (Roszdravnadzor) last week in Moscow.

Ingredients